Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
07 May 2024
Regulated information

Securities Note Open in new window

07 May 2024
Financial statements and reports, Regulated information

AMENDMENT TO THE 2023 UNIVERSAL REGISTRATION DOCUMENT Open in new window

17 April 2024
Financial statements and reports

2023 Universal Registration Document Open in new window

10 January 2024
General meetings

EGM January 10, 2024 – Results Open in new window

22 December 2023
General meetings

Proxy card – EGM January 10, 2024 Open in new window

22 December 2023
General meetings

Convening notice – EGM January 10, 2024 Open in new window

22 December 2023
General meetings

Statutory Auditors Report – Resolution 8 Open in new window

22 December 2023
General meetings

Notice of Extraordinary General Meeting – EGM January 10, 2024 Open in new window

22 December 2023
General meetings

Statutory Auditors Report – Resolution 7 Open in new window

22 December 2023
General meetings

Shares and voting rights statement – December 6, 2023 Open in new window

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 24
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page